SCHEMBL5445772

SCHEMBL5445772

COc1ccc(-c2c(C3CCCCC3)c3ccc(C(=O)O)cc3n2CC(=O)N2CCC(N3CCCC3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBX7 O95931 2/20 0.49
CDYL2 Q8N8U2 2/20 0.49
CDYL Q9Y232 2/20 0.49
ACHE P22303 2/20 0.43
TSHR P16473 2/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 1/20 0.41
CHRM2 P08172 3/20 0.40
CHRM1 P11229 3/20 0.40
CHRM3 P20309 1/20 0.40
PTGS2 P35354 1/20 0.40
CDY1; CDY1B Q9Y6F8 1/20 0.40
L3MBTL3 Q96JM7 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
PRKCA P17252 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5442463 0.98 CBX7 (0.47) CBX7CDYL2CDYLACHETSHR
SCHEMBL14468939 0.93 CHRM2 (0.41) CBX7CDYL2CDYLACHECHRM2
SCHEMBL14468731 0.91 CHRM2 (0.40) CBX7CDYL2CDYLCHRM2CHRM1
SCHEMBL5448433 0.89 POLB (0.49) CBX7CDYL2CDYLACHETSHR
SCHEMBL5434937 0.89 PTGS2 (0.46) TSHRPOLBGAAKMT2AALDH1A1
SCHEMBL5198176 0.88 GRIN1 (0.46) TSHRPOLBGAAKMT2AALDH1A1
SCHEMBL5402763 0.88 CYP2C9 (0.43) CBX7CDYL2CDYLACHETSHR
SCHEMBL5442324 0.87 PRKCA (0.42) CBX7CDYL2CDYLKMT2AALDH1A1
SCHEMBL5398126 0.85 SCN9A (0.46) CBX7CDYL2CDYLACHETSHR
SCHEMBL5433798 0.82 POLB (0.49) CBX7CDYL2CDYLACHETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase ISTITUTO DI RICERCHE DI BIOLOGIA DI MOLECULOARE P. ANGELETTI SPA (IT) 2007-07-19 US claimed
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase ISTITUTO DI RICERCHE DI BIOLOGIA DI MOLECULOARE P. ANGELETTI SPA (IT) 2007-07-19 US disclosed
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase ISTITUTO DI RICERCHE DI BIOLOGIA DI MOLECULOARE P. ANGELETTI SPA (IT) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase IDO1, NAT1, AANAT CBX7 1840/4885CDYL2 1724/4885CDYL 1358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.